News

GVK BIO appoints Axel Schleyeras Chief Executive Officer for subsidiary Aragen Bioscience

GVK BIO has announced the appointment of Dr Axel Schleyer as Chief Executive Officer, Aragen Bioscience Inc.

May 09, 2019

By : Team ABLE

Dyadic, Serum Institute of India partner to manufacture affordable antibody products and vaccines

According to both the companies, this collaboration is focused on making biologic vaccines & drugs accessible and more affordable to patients worldwide while lowering the financial burden on the global healthcare system.

May 09, 2019

By : Team ABLE

PrediLife,Institut Curie partner on genetic analyses for test predicting breast cancer risk

MammoRisk is a test complementing mammograms that predicts the risk of breast cancer by taking into account5 risk factors.

May 07, 2019

By : Team ABLE

Proteintech appoints Dr Deepa Shankar as Head of R&D

Dr Deepa Shankar will be leading a team of over 150 scientists in the R&D and technological operations in Proteintech

May 07, 2019

By : Team ABLE

Pandorum Technologies' scientists accomplish development of bio-engineered cornea tissue

Pandorum's scientists have bio-engineered cornea tissue for scarless regeneration and vision restoration. A pre-clinical data was presented at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO-2019), Vancouver, Canada.

May 06, 2019

By : Team ABLE